Skip to main content

ORTHOPEDIATRICS CORP

For the period ended Sep 30, 2024. Filed Nov 7, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 7, 2024

KIDS$33.99+7.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets - September 30, 2024 and December 31, 2023

CONDENSED CONSOLIDATED BALANCE SHEETS

September 30, 2024December 31, 2023
ASSETS
Current assets:
Cash and cash equivalents$51,047$31,055
Restricted cash1,9981,972
Short-term investments25,01749,251
Accounts receivable - trade, net of allowances of $1,025 and $1,373, respectively42,82734,617
Inventories, net120,934105,851
Prepaid expenses and other current assets6,4893,750
Total current assets248,312226,496
Property and equipment, net54,76541,048
Other assets:
Amortizable intangible assets, net65,95569,275
Goodwill91,26283,699
Other intangible assets18,74415,287
Other non-current assets10,2562,940
Total other assets186,217171,201
Total assets$489,294$438,745
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable - trade$11,647$12,649
Accrued compensation and benefits13,22111,325
Current portion of long-term debt with affiliate158152
Current portion of acquisition installment payable1,32510,149
Other current liabilities8,2747,391
Total current liabilities34,62541,666
Long-term liabilities:
Long-term term loan23,9489,297
Long-term convertible note47,831—
Long-term debt with affiliate, net of current portion491611
Other long-term debt, net of current portion244—
Acquisition installment payable, net of current portion2,4123,551
Deferred income taxes4,0255,483
Other long-term liabilities4,7991,112
Total long-term liabilities83,75020,054
Total liabilities118,37561,720
Stockholders' equity:
Common stock, $0.00025 par value; 50,000,000 shares authorized; 24,214,046 shares and 23,378,408 shares issued as of September 30, 2024 and December 31, 2023, respectively66
Additional paid-in capital597,009580,287
Accumulated deficit(219,495)(197,742)
Accumulated other comprehensive loss(6,601)(5,526)
Total stockholders' equity370,919377,025
Total liabilities and stockholders' equity$489,294$438,745
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.